BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $270,000 | -43.0% | 3,356 | -39.0% | 0.07% | -47.5% |
| Q2 2020 | $474,000 | +0.9% | 5,500 | -4.9% | 0.14% | -19.4% |
| Q1 2020 | $470,000 | -61.6% | 5,785 | -60.4% | 0.18% | -45.3% |
| Q4 2019 | $1,223,000 | -16.2% | 14,627 | -12.4% | 0.32% | -24.7% |
| Q3 2019 | $1,460,000 | -52.7% | 16,691 | -55.7% | 0.42% | -53.1% |
| Q2 2019 | $3,088,000 | -5.9% | 37,708 | -6.5% | 0.91% | -9.4% |
| Q1 2019 | $3,280,000 | +36.5% | 40,340 | +10.5% | 1.00% | +14.4% |
| Q4 2018 | $2,403,000 | -16.6% | 36,507 | -2.3% | 0.88% | -4.9% |
| Q3 2018 | $2,880,000 | +70.3% | 37,362 | +63.2% | 0.92% | +20.4% |
| Q2 2018 | $1,691,000 | +61.7% | 22,899 | +42.4% | 0.76% | +105.9% |
| Q1 2018 | $1,046,000 | -3.9% | 16,086 | -4.5% | 0.37% | -3.1% |
| Q4 2017 | $1,089,000 | -10.4% | 16,846 | -13.0% | 0.38% | -19.5% |
| Q3 2017 | $1,215,000 | +0.4% | 19,366 | -3.1% | 0.48% | -11.0% |
| Q2 2017 | $1,210,000 | +13.0% | 19,981 | -3.2% | 0.54% | +1.1% |
| Q1 2017 | $1,071,000 | +18.1% | 20,651 | +1.0% | 0.53% | +9.3% |
| Q4 2016 | $907,000 | -7.2% | 20,451 | -0.3% | 0.48% | -7.1% |
| Q3 2016 | $977,000 | +5.1% | 20,521 | -0.2% | 0.52% | +0.6% |
| Q2 2016 | $930,000 | +27.4% | 20,556 | +15.7% | 0.52% | +47.2% |
| Q1 2016 | $730,000 | -7.4% | 17,772 | -14.0% | 0.35% | -23.3% |
| Q4 2015 | $788,000 | +30.5% | 20,662 | +12.3% | 0.46% | +15.6% |
| Q3 2015 | $604,000 | -20.8% | 18,397 | +68.6% | 0.40% | -11.4% |
| Q2 2015 | $763,000 | +52.0% | 10,912 | +48.9% | 0.45% | +28.0% |
| Q1 2015 | $502,000 | +2.7% | 7,327 | +9.9% | 0.35% | -17.6% |
| Q4 2014 | $489,000 | – | 6,667 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |